Expression systems
US10059961B2 · kind B2 · utility
3Cited by
17References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 28, 2015 |
| Grant date | Aug 28, 2018 |
| Priority date | — |
| Expiry date | Aug 28, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/008
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A gene expression system is provided. The system comprises at least one coding sequence to be expressed in an organism, and at least one promoter operably linked thereto. It further comprises at least one splice control sequence which, in cooperation with a spliceosome, mediates alternative splicing of RNA transcripts of the coding sequence. The mediation of alternative splicing is in a sex-specific, stage-specific, germline-specific and tissue-specific manner.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.